title: An open trial of olanzapine in children and adolescents with Asperger Disorder.
authors.forename: Robert
authors.initials: R
authors.lastname: Milin
authors.forename: Jovan G
authors.initials: JG
authors.lastname: Simeon
authors.forename: Sue
authors.initials: S
authors.lastname: Batth
authors.forename: Smita
authors.initials: S
authors.lastname: Thatte
authors.forename: Glenda J
authors.initials: GJ
authors.lastname: Dare
authors.forename: Selena
authors.initials: S
authors.lastname: Walker
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020817:Asperger Syndrome / Q000188:drug therapy*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine